WINTON GROUP Ltd - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 134 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.

Quarter-by-quarter ownership
WINTON GROUP Ltd ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$227,000
-60.1%
25,197
-47.0%
0.01%
-58.1%
Q2 2021$569,000
+4.4%
47,528
+9.3%
0.03%0.0%
Q1 2021$545,000
+9.9%
43,467
+36.6%
0.03%
-13.9%
Q4 2020$496,000
+89.3%
31,813
+14.7%
0.04%
+300.0%
Q3 2020$262,000
-67.4%
27,733
-69.1%
0.01%
-57.1%
Q2 2020$804,000
+318.8%
89,765
+197.6%
0.02%
+320.0%
Q1 2020$192,000
-78.7%
30,168
-71.9%
0.01%
-61.5%
Q4 2019$900,000107,5420.01%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Alexandria Capital, LLC 1,003,725$15,663,0001.66%
Golden State Equity Partners 123,817$1,932,0001.33%
Rhenman & Partners Asset Management AB 821,888$12,826,0001.05%
WASATCH ADVISORS LP 10,072,381$157,180,0000.77%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,636$462,0000.73%
Ceeto Capital Group, LLC 80,000$1,248,0000.63%
EMC Capital Management 48,992$765,0000.58%
Fort Sheridan Advisors LLC 71,173$1,111,0000.54%
Vanguard Capital Wealth Advisors 34,680$584,0000.54%
Casdin Capital, LLC 1,080,000$16,853,0000.50%
View complete list of SANGAMO THERAPEUTICS INC shareholders